State Ledger
Company profile

Alto Neuroscience, Inc. CIK 1999480

Ticker
ANRO (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Mountain View, CA 94041
Fiscal year end
2025 (FY)
Market Data
Close
$24.18
Change
-$0.19
Change %
-0.78%
Volume
22,575

ANRO · trading date Oct 12, 2026 · previous close $24.37 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$63.24M
Total assets
$184.69M
Total liabilities
$33.55M
Stockholders' equity
$151.14M
Cash & equivalents
$176.48M
Operating income
-$66.36M
Operating cash flow
-$51.77M
Capital expenditures
$24.0K

Fiscal year 2025, via 10-K filed 2026-03-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$51.79M
Free cash flow margin
—
Liabilities / assets
18.2%
Equity / assets
81.8%
CapEx / revenue
—
Operating cash flow / net income
0.82×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$63.24M $184.69M $33.55M $151.14M
2024 — -$61.43M $177.54M $26.08M $151.46M
2023 — -$36.31M $86.63M $16.82M -$71.67M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-27
Financials filed via
Form 10-K
filed 2026-03-16

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Mountain View, CA 94041
650 CASTRO STREET, SUITE 450
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:20 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies